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Abstract
The pathogenic fungus Candida albicans switches from yeast growth to filamentous growth in response to genotoxic
stresses, in which phosphoregulation of the checkpoint kinase Rad53 plays a crucial role. Here we report that the Pph3/Psy2
phosphatase complex, known to be involved in Rad53 dephosphorylation, is required for cellular responses to the DNA-
damaging agent methyl methanesulfonate (MMS) but not the DNA replication inhibitor hydroxyurea (HU) in C. albicans.
Deletion of either PPH3 or PSY2 resulted in enhanced filamentous growth during MMS treatment and continuous
filamentous growth even after MMS removal. Moreover, during this growth, Rad53 remained hyperphosphorylated, MBF-
regulated genes were downregulated, and hypha-specific genes were upregulated. We have also identified S461 and S545
on Rad53 as potential dephosphorylation sites of Pph3/Psy2 that are specifically involved in cellular responses to MMS.
Therefore, our studies have identified a novel molecular mechanism mediating DNA damage response to MMS in C.
albicans.
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Introduction
Candida albicans is a pleiomorphic fungus that can grow in three
different morphological forms: budding yeast, pseudohyphae and
hyphae [1,2], rendering it an excellent model for studying cell
morphogenesis [2–5]. The yeast-to-hyphal growth transition has
been implicated in its virulence in various human superficial
infections of the skin, vagina and oral epithelia [5–9]. Therefore,
understanding the underlying mechanisms that regulate the
morphological transition may provide key insights into potential
strategies for developing antifungal therapeutics.
Earlier studies showed that the cAMP/protein kinase A (PKA)
and mitogen-activated protein (MAP) kinase pathways play key
roles in regulating the hyphal growth of C. albicans [7,10,11].
Recently, many studies revealed cell cycle checkpoints as part of
alternative regulatory pathways mediating filamentous growth
under various conditions that block cell cycle progression [12,13].
For example, depletion of the G1 cyclin Cln3 [14,15], or the
mitotic cyclin Clb2 or Clb4 [16], or deletion of other cell cycle
regulatory genes such as CDC4o rCDC5 were shown to result in
filamentous growth [17,18]. Filamentous growth was also observed
in several C. albicans deletion mutants defective in DNA damage
repair [19,20]. DNA damaging agents were found to cause cell
cycle arrest and filamentous growth in a manner dependent on the
DNA damage/replication checkpoint kinase Rad53 [21].
Rad53, the yeast homolog of human Chk2 [22,23], is a Ser/Thr
kinase that plays a pivotal role in G2/M checkpoint regulation by
phosphorylating various substrates involved in cell cycle pro-
gression and/or DNA damage repair [24–26]. Hyperphosphor-
ylation of Rad53 is sufficient for cell cycle arrest and its
dephosphorylation leads to recovery after genotoxic stress [27–
29]. Previous studies revealed diverse phosphorylation and de-
phosphorylation patterns on Rad53 under different circumstances.
The phosphorylation mainly occurs in the two SQ cluster domains
(SCDs). The N-terminal SCD is conserved in human Chk2, while
the C-terminal SCD is unique to the yeast homologs. Several
protein kinases such as Mec1, Mrc1 and Rad9 [27,30–32] and
phosphatases Pph3 and Ptc2 are involved in regulating Rad53
phosphorylation [28,33,34]. However, the sites of phosphoryla-
tion/dephosphorylation by different kinases and phosphatases and
their regulation and biological significance of the phosphorylation
state of particular sites remain largely unknown. It was reported
that Pph3 binds to the central kinase domain of Rad53, while Ptc2
binds to its FHA1 domain, and that their deletion led to sensitivity
to different genotoxic stresses [35]. However, the underlying
molecular mechanisms remain elusive.
In this study, we examined the role of the phosphatase Pph3/
Psy2 in regulating cellular responses to MMS and HU in C.
albicans. We investigated how deletion of the phosphatase genes
affected Rad53 phosphorylation and its ability to regulate
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37246downstream signaling and cell morphogenesis. We also obtained
evidence on the potential sites for Pph3/Psy2 dephosphorylation
on Rad53.
Results
pph3D and psy2D mutants exhibited hypersensitivity to
MMS but not HU
Previous studies in Saccharomyces cerevisiae demonstrated that
PPH3 deletion led to hypersensitivity towards MMS but not HU
[34]. Thus, we first determined whether the same phenomenon
also occurs in C. albicans. Wild-type, pph3D and psy2D yeast cells
(Table 1) were inoculated into liquid YPD medium containing
different concentrations of MMS or HU and incubated at 30uC
for 6 h, followed by recovery in fresh drug-free YPD medium for
8 h at 30uC. Microscopic examination of the genotoxin-induced
cell elongation at timed intervals revealed that both pph3D and
psy2D mutants exhibited cell elongation during HU treatment and
returned to the yeast form of growth after drug removal in
manners comparable to wild-type cells (Fig. 1A, left & Fig. S2). In
comparison, during MMS treatment the mutant cells exhibited
faster elongation than wild-type cells and continued to elongate
throughout the entire recovery period, while the wild-type cells
returned to yeast growth ,2 h after shifting to the drug free
medium (Fig. 1A, right & Fig. S1).
Flow cytometry analysis showed that wild-type cells were
arrested with a 2C DNA content after 2 h MMS treatment, but
pph3D and psy2D mutants appeared to progress slowly through or
arrested in S phase (Fig. 1B, left). In comparison, all three strains
responded similarly to HU treatment, exhibiting a slow pro-
gression through S phase (Fig. 1B, right). In addition, both the
pph3D and psy2D mutants reentered the cell cycle 4 h after HU
removal (Fig. 1C, right), but remained arrested in S phase even 4 h
after MMS removal (Fig. 1C, left).
Furthermore, wild-type cells adapted to MMS after several
hours as reported for S. cerevisiae [37,38]. Even in the continuous
presence of the genotoxin, wild-type cells were able to exit from
the DNA damage-induced cell cycle arrest, re-enter the cell cycle,
and switch from filamentous growth back to yeast growth (Fig, S1).
In contrast, pph3D and psy2D cells remained arrested and
continued to elongate for a long period of time before finally
losing viability. This phenomenon was not observed with HU
treatment (Fig. S2). Hence, we conclude that Pph3/Psy2 has a role
in regulating cellular response to MMS but not HU in C. albicans.
Deletion of PPH3 and PSY2 resulted in Rad53
hyperphosphorylation
Rad53 was shown to be a substrate of the Pph3/Psy2 complex
in both S. cerevisiae and C. albicans [34,38]. Furthermore, Rad53
hyperphosphorylation was shown to cause cell cycle arrest and
filamentous growth in C. albicans [38]. Next, we examined the
phosphorylation state of Rad53 in response to MMS and HU
treatment. Western blotting of C-terminally Myc-tagged Rad53
demonstrated that in wild-type cells Rad53 was hyperpho-
sphorylated after both MMS (Fig. S3B) and HU treatment (Fig.
S3A), and became dephosphorylated 6 h after HU or MMS
removal (Fig. 2A&B). Both pph3D and psy2D mutants also showed
a similar course of Rad53 dephosphorylation after HU removal
(Fig. 2A). However, Rad53 hyperphosphorylation persisted in
pph3D and psy2D mutants even at 6 h after MMS removal (Fig. 2B),
indicating that Rad53 dephosphorylation during recovery from
MMS treatment is dependent on the Pph3/Psy2 complex.
Deletion of PPH3 and PSY2 resulted in dysregulated gene
expression
Next, we investigated the physiological significance of Rad53
hyperphosphorylation. Swi6p was demonstrated in S. cerevisiae to
be phosphorylated by Rad53 to trigger G1 arrest by inhibiting the
transcriptional activity of MBF [39,40]. MBF is the Mbp1/Swi6
transcriptional complex that regulates the expression of various
genes related to cell cycle progression. Therefore, we examined the
expression of MBF-regulated genes [40–42] by RT-PCR, qPCR
and Northern blot analysis in C. albicans during MMS treatment
and the recovery from it.
Results showed that there is an overall downregulation of MBF-
regulated genes, such as MSH2, RFA2, CCN1 and PCL2, upon
MMS treatment and during recovery in the pph3D or psy2D
mutant as compared to wild-type cells (Fig. 3A&B). Upon MMS
treatment, upregulation of MSH2, RFA2 and CCN1 was observed
in wild-type, but to a minor level in the pph3D and psy2D mutant;
while PCL2 was downregulated in all three strains (Fig. 3A–C).
Higher than normal levels of MSH2, CCN1 and RFA2 persisted in
wild-type cells after recovery, while RFA2 returned to normal
levels in the pph3D and psy2D mutant during recovery (Fig. 3B&C).
In contrast, PCL2 exhibited higher-than-normal expression levels
after MMS recovery in wild-type cells, but exhibited near normal
expression levels after recovery in the pph3D and psy2D mutant
(Fig. 3B&C). Negative controls without reverse transcriptase was
used in the RT-PCR experiments to rule out genomic DNA
contamination during PCR amplification (Fig. 3A). GADPH was
used as loading control, and rRNA was included to indicate RNA
integrity in Northern blot experiment (Fig. 3B).
Because filamentous growth was observed after MMS treat-
ment, we also examined the expression of several known hypha-
specific genes including HWP1, EBP1, ECE1, ALS3, SAP4 and
UME6. Interestingly, expression of hypha-specific genes was
significantly higher in pph3D and psy2D cells than in wild-type
cells during MMS recovery (Fig. 3A&B). Hence, this phenomenon
is consistent with the observed cell elongation in C. albicans upon
MMS treatment (Fig. S1). In addition to hypha-specific genes, we
also monitored the cyclin gene CLB4 and its inhibitor SIC1. CLB4
showed sustained downregulation in both the pph3D and psy2D
mutant as compared to wild type cells. In contrast, expression of its
inhibitor gene SIC1 was higher in pph3D and psy2D cells than in
wild-type cells under normal conditions and increased further after
MMS treatment (Fig. 3A), supporting the observation that pph3D
and psy2D cells were unable to recover from cell cycle arrest.
However, whether these phenomena are directly related to Rad53
remains to be investigated.
Northern blot (Fig. 3C) and qPCR (Fig. 4D) analyses produced
consistent results in the expression levels of MSH2, RFA2, CCN1,
PCL2 and HWP1, which are genes involved in either cell cycle
regulation or hyphal growth. Among these genes, downregulation
of RFA2 in pph3D and psy2D mutants after MMS recovery was
further confirmed by Western blot analyses (Fig. 4D). Therefore,
our results suggest that Rad53 hyperphosphorylation resulting
from PPH3 and PSY2 deletion triggers its downstream signaling,
which may contribute to MMS sensitivity.
Pph3 and Ptc2 are two phosphatases that have been implicated
in Rad53 dephosphorylation during genotoxic stress [28,33,34].
Next, we asked whether RFA2 downregulation during MMS
treatment is specific to PPH3 deletion. To this end, we spotted
BWP17, pph3D, psy2D, ptc2D and pph3D ptc2D cells onto YPD
plates containing different concentrations of MMS or HU, and
incubated at 30uC for 24 h. Results showed that in the absence of
genotoxin, the pph3D, psy2D and ptc2D mutant exhibited normal
growth indistinguishable from the wild-type strain; however, the
Pph3 Dephosphorylation of Rad53
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degree of functional redundancy between Pph3 and Ptc2 in cell
growth. In the presence of genotoxins, while all mutants showed
increased sensitivity, the pph3D ptc2D mutant was the most
sensitive (Fig. 4A&B), indicating that Pph3 and Ptc2 have both
independent and redundant functions important for cell viability
in response to genotoxic stress. Ptc2 seemed to play a lesser role in
MMS sensitivity than Pph3, because the ptc2D mutant displayed
lower MMS sensitivity than both the pph3D and psy2D mutant
(Fig. 4A&B). All the single-gene deletion mutants exhibited similar
sensitivity to HU (Fig. 4A&B). Western blotting of Rfa2-Myc in
pph3D, psy2D, ptc2D and pph3D ptc2D mutants showed that Rfa2
cellular levels were comparable in HU-treated mutant cells
(Fig. 4C). In comparison, its cellular level diminished significantly
after MMS treatment in pph3D, psy2D and pph3D ptc2D mutants,
while remained unaffected in wild-type and ptc2D cells (Fig. 4D).
Therefore, these results suggest that downregulation of Rfa2 is
closely associated with Pph3 dephosphorylation of Rad53.
Double bands were observed of Rfa2 after HU and MMS
treatment (Fig. 4C&D). Previous studies demonstrated that RPA2,
the human homolog of Rfa2, is hyperphosphorylated under
various genotoxic stresses [43–48]. Thus, the upper band may
represent phosphorylated Rfa2. However, we have not studied the
post-translational modification of Rfa2. Nevertheless, this should
not compromise our conclusion that Rfa2 downregulation is
a result of PPH3 deletion.
Identification of potential MMS-related
dephosphorylation sites on Rad53
To identify potential phosphorylation sites on Rad53 that may
be responsible for MMS sensitivity, we performed phosphomi-
metic mutagenesis on previously reported phosphorylation sites
(Fig. 5A). Results showed that the Rad53 phosphomimetic
mutants of S461D and S545D (corresponding to 489 and 560 in
S. cerevisiae, GeneID 855950) exhibited higher sensitivity to MMS
but not HU than the wild-type strain (Fig. 5B). Viability of these
Figure 1. pph3D and psy2D cells exhibit pseudohyphal growth and cell cycle arrest when treated with MMS or HU. Fig 1A. Wild-type
(SC5314 or BWP17), pph3D (SJL3) and psy2D (SJL6) cells were grown in liquid YPD medium supplemented with 0.02% MMS or 20 mM HU at 30uC for
6 h, washed with fresh YPD and resuspended into fresh YPD for further growth at 30uC for 8 h. Bud length was measured using ImageJ (http://
rsbweb.nih.gov/ij/index.html). Each data point represents the average of 30 cells measured in 3 independent experiments. Fig 1B. The same cells as
used in (A) were treated with 0.02% MMS or 20 mM HU. Cells were harvested at indicated time intervals for flow cytometry analysis. Fig 1C. The same
cells as used in (A) were treated with 0.02% MMS or 20 mM HU at 30uC for 6 h and recovered in fresh YPD as described in (A). Cells were harvested at
indicated time intervals for flow cytometry analysis.
doi:10.1371/journal.pone.0037246.g001
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were able to recover from HU treatment (Fig. 5C, Table 2).
Moreover, the two mutants remained in pseudohyphal form 10 h
after MMS withdrawal, but could fully return to the yeast growth
after HU treatment (Fig. 5D, Table 2).
On the other hand, the Rad53-S351D mutant (corresponding
to S375 in S. cerevisiae Rad53p) exhibited higher sensitivity to both
HU and MMS as compared to wild-type and the Rad53-S461D
and Rad53-S545D mutants (Fig. 5B). However, it could partially
recover from both HU and MMS treatment (Table 2), suggesting
Table 1. C. albicans strains used in this study.
Strains Relevant genotype Source
SC5314 Wild type, clinical isolate
BWP17 ura3/ura3 his1::hisG/his1::hisG arg4::hisG/arg4::hisG [69]
SJL2 BWP17 pph3D::ARG4/pph3D::HIS1 [36]
SJL2.1 BWP17 pph3D::ARG4/pph3D::HIS1 PPH3:URA3 [36]
SJL3 BWP17 pph3D::ARG4/pph3D::HIS1 URA3 [36]
SJL5 BWP17 psy2D::ARG4/psy2D::HIS1 [36]
SJL5.1 BWP17 psy2D::ARG4/psy2D::HIS1 PSY2:URA3 [36]
SJL6 BWP17 psy2D::ARG4/psy2D::HIS1 URA3 [36]
SJL7 BWP17 pph3D::ARG4/pph3D::HIS1 RAD53-Myc:URA3 [36]
SJL8 BWP17 psy2D::ARG4/psy2D::HIS1 RAD53-Myc:URA3 [36]
SJL9 BWP17 RAD53-Myc-URA3 [36]
HKD1 BWP17 ptc2D::ARG4/ptc2D::HIS1 unpublished
HKD1.1 BWP17 ptc2D::ARG4/ptc2D::HIS1 URA3 unpublished
HKD2 BWP17 pph3D::ARG4/pph3D::HIS1 ptc2D::FRT/ptc2D::FRT URA3 unpublished
HT1 BWP17 RFA2-Myc-URA3 This study
HT2 BWP17 pph3D::ARG4/pph3D::HIS1 RFA2-Myc:URA3 This study
HT3 BWP17 psy2D::ARG4/psy2D::HIS1 RFA2-Myc:URA3 This study
HT4 BWP17 ptc2D::ARG4/ptc2D::HIS1 RFA2-Myc:URA3 This study
HT5 BWP17 pph3D::ARG4/pph3D::HIS1 ptc2D::FRT/ptc2D::FRT RFA2-Myc:URA3 This study
WY3 rad53D::ARG4/rad53D::URA3 [19]
HT6 rad53D::ARG4/rad53D::URA3 RAD53:HIS1 This study
HT7 rad53D::ARG4/rad53D::URA3 rad53T327A:HIS1 This study
HT8 rad53D::ARG4/rad53D::URA3 rad53T327D:HIS1 This study
HT9 rad53D::ARG4/rad53D::URA3 rad53S350A:HIS1 This study
HT10 rad53D::ARG4/rad53D::URA3 rad53S350D:HIS1 This study
HT11 rad53D::ARG4/rad53D::URA3 rad53S351A:HIS1 This study
HT12 rad53D::ARG4/rad53D::URA3 rad53S351D:HIS1 This study
HT13 rad53D::ARG4/rad53D::URA3 rad53S461A:HIS1 This study
HT13.1 rad53D::ARG4/rad53D::URA3 rad53S461A-Myc:HIS1 This study
HT14 rad53D::ARG4/rad53D::URA3 rad53S461D:HIS1 This study
HT14.1 rad53D::ARG4/rad53D::URA3 rad53S461D-Myc:HIS1 This study
HT15 rad53D::ARG4/rad53D::URA3 rad53S545A:HIS1 This study
HT15.1 rad53D::ARG4/rad53D::URA3 rad53S545A-Myc:HIS1 This study
HT16 rad53D::ARG4/rad53D::URA3 rad53S545D:HIS1 This study
HT16.1 rad53D::ARG4/rad53D::URA3 rad53S545D-Myc:HIS1 This study
HT17 rad53D::ARG4/rad53D::URA3 rad53S695A:HIS1 This study
HT18 rad53D::ARG4/rad53D::URA3 rad53S695D:HIS1 This study
HT19 rad53D::ARG4/rad53D::URA3 rad53S455A/S457A/S459A/S461A:HIS1 This study
HT20 rad53D::ARG4/rad53D::URA3 rad53S455D/S457D/S459D/S461D:HIS1 This study
HT21 rad53D::ARG4/rad53D::FRT rad53S461A:HIS1 RFA2-Myc:URA3 This study
HT22 rad53D::ARG4/rad53D::FRT rad53S461D:HIS1 RFA2-Myc:URA3 This study
HT23 rad53D::ARG4/rad53D::FRT rad53S545A:HIS1 RFA2-Myc:URA3 This study
HT24 rad53D::ARG4/rad53D::FRT rad53S545D:HIS1 RFA2-Myc:URA3 This study
doi:10.1371/journal.pone.0037246.t001
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S461 and S545. Furthermore, the stronger phenotype of the S to
D mutation at the residues of S351, S461 and S545 suggests that
phosphorylation at these sites potentially affects kinase function.
Therefore, we conclude that phosphorylation at S461 and S545
appears to have a more important role in determining MMS
sensitivity.
To gain evidence that phosphorylation at the above residues on
Rad53 is biologically relevant, we first confirmed that the S to D
mutants resulted in sustained Rad53 hyperphosphorylation after
MMS treatment and recovery (Fig. 6A) but not HU (Fig. S4).
Next, we used qPCR to examine the expression of Rad53
downstream genes after MMS treatment and recovery. qPCR
results showed that RFA2 as well as the cyclin genes of CCN1 and
PCL2 were downregulated in both Rad53-S461D and Rad53-
S545D mutants after MMS treatment and during the recovery,
while there was no obvious difference between the Rad53-S461A
and Rad53-S545A mutants and the wild type (Fig. 6B). Western
blotting analysis revealed that Rfa2 levels were not recovered in
the Rad53-S461D and Rad53-S545D mutants, similar to results
obtained in the pph3D mutant (Fig. 6C). Hence, our results strongly
suggest that failure of dephosphorylation at S461 and S545 on
Rad53 may be responsible for the MMS-induced pseudohyphal
growth and sensitivity in pph3D and psy2D mutants.
Discussion
We have previously shown that Pph3 and its regulatory subunit
Psy2 are required for recovery from MMS and cisplatin treatment
in C. albicans [38]. Here, we demonstrated that pph3D and psy2D
mutants exhibited hypersensitivity to MMS but not HU, consistent
with earlier discoveries in S. cerevisiae [34]. Moreover, our results
demonstrate that such hypersensitivity is closely related to
CaRad53 hyperphosphorylation and that Pph3/Psy2 plays
a pivotal role. Consistent with our results, Bazzi, et al. [49]
showed that Glc7 but not Pph3 promoted disappearance of
hyperphosphorylated Rad53 and cell’s recovery after HU
treatment.
Hyperphosphosphorylation of CaRad53 was observed in our
pph3D and psy2D mutants upon MMS treatment. Rad53 is the
yeast homolog of the mammalian tumor suppressor Chk2. It is an
important checkpoint kinase that is activated in response to
genotoxic stress and deactivated upon stress removal in order to
exit from cell cycle arrest [23]. Rad53 deactivation is achieved
through its dephosphorylation by various phosphatatases including
the human PP4 homolog of Pph3, the human PP2C homologs of
Ptc2 and Ptc3 [28], and the human PP1 homolog of Glc7 [49]. A
large body of evidence demonstrated that different phosphoryla-
tion patterns prevail on Rad53 under different genotoxic stresses.
This is regulated by different activities of various kinases and
phosphatases, some of which may be redundant. For instance,
pph3D cells are hypersensitive to phleomycin, while ptc2D, ptc3D
and ptc2D ptc3D cells are not; on the contrary, ptc2D ptc3D cells are
hypersensitive to 4-NQO while pph3D mutants are not [35].
Alternatively, Glc7, but not Ptc2, Ptc3 or Pph3, is required for
recovery from an HU-induced checkpoint, while it is dispensable
for checkpoint inactivation during MMS exposure. Here, we
observed that the pph3D ptc2D double KO mutant exhibited higher
sensitivity to MMS than the pph3D mutant, suggesting a possible
role for Ptc2 in MMS sensitivity in C. albicans. Hence, a consensus
is that different signaling pathways are activated in response to
different genotoxic stresses, leading to different phosphorylation
patterns of Rad53 and activation of different downstream signaling
pathways.
Swi6 is a substrate of Rad53 and controls the G1/S cell cycle
checkpoint. It interacts with Swi4 in the SBF complex associates
with Mbp1 in the MBF complex in S. cerevisiae [50–54]. The SBF/
MBF complexes are regulated through phosphorylation of Swi6 by
Rad53. In S. cerevisiae, Rad53-dependent phosphorylation of Swi6
delayed the transition to S phase, possibly by inhibiting CLN
transcription [46]. In C. albicans, cells lacking Swi4 and Swi6
demonstrated pronounced downregulation of the G1 cyclin genes
CCN1 and PCL2 [55]. We observed a similar scenario of
downregulation of MBF-regulated genes in the pph3D mutant
upon MMS treatment. In addition, RFA2 downregulation was
only observed in the pph3D mutant but not in the ptc2D mutant
upon MMS treatment, providing evidence for a Pph3-mediated
dephosphorylation event specific for regulating the transcription of
one, if not all, Swi6-regulated genes. Therefore, we deduce that
such phenomenon results from the dysregulation of Pph3-de-
pendent dephosphorylation of CaRad53.
Furthermore, downregulation of Rfa2 might also contribute to
the pseudohyphal phenotype in the pph3D mutant upon MMS
treatment in addition to the downregulation of SBF/MBF genes.
Rfa2 is a conserved single strand DNA (ssDNA) binding protein
that forms a heterotrimeric complex with two other subunits Rfa1
and Rfa3 to stabilize ssDNA during DNA replication, repair and
recombination [56,57]. RFA2 mutations were demonstrated to
induce S phase arrest in S. cerevisiae [58]. Here, we demonstrated
that Rfa2 was downregulated upon Rad53 hyperphosphorylation
in pph3D mutant. Thus, it is likely that changes in Rfa2 cellular
levels contribute to the hyphal growth of C. albicans in addition to
the downregulation of SBF/MBF genes.
Numerous studies have investigated the phosphorylation status
of Rad53 under different genotoxic stresses [32,59–62]. Different
Figure 2. Rad53 undergoes hyperphosphorylation in response
to HU and MMS. Fig 2A. Rad53 hyperphosphorylation in HU-treated
cells. SJL9 (wild type with RAD53-Myc), SJL7 (pph3D RAD53-Myc), and
SJL8 (psy2D RAD53-Myc) cells were incubated at 30uC in YPD containing
20 mM HU for 4 h. Cells were then washed and recovered with fresh
YPD for the indicated times. Whole cell lysates were used for
immunoblot analysis with anti-Myc antibody. Untreated cells were
used as control. Cdc28 was probed with anti-PSTAIRE antibody as
loading control. Fig 2B. Rad53 hyperphosphorylation in MMS-treated
cells. SJL9 (wild type with RAD53-Myc), SJL7 (pph3D RAD53-Myc), and
SJL8 (psy2D RAD53-Myc) cells were incubated at 30uC in YPD containing
0.02% MMS for 4 h. Cells were then washed and recovered with fresh
YPD for the indicated times. Whole cell lysates were used for
immunoblot analysis with anti-Myc antibody. Untreated cells were
used as control. Cdc28 was probed with anti-PSTAIRE antibody as
loading control.
doi:10.1371/journal.pone.0037246.g002
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spectrometry analysis after MMS, HU and 4-NQO treatment
[32,59]. Based on these results together with sequence alignment,
we mutated Thr327, Ser350, Ser351, Ser461, Ser545 and Ser695
in C. albicans Rad53 which correspond to Ser350, Ser373, Ser375,
Ser489, Ser560 and Ser747 in S. cerevisiae Rad53 respectively. We
observed that the S461D and S545D single amino-acid mutants
(Figure 5, Table 2), and the S455D/S457D/S459D/S461D
quadruple mutant (Table 2), which are located in the C-terminal
SCD (SQ Cluster Domain), displayed stronger phenotypes than
their S to A counterparts upon MMS treatment. Sweeney [63]
provided evidence that a truncated fragment of ScRad53 (aa170–
512) containing S485E/S489E mutations (corresponding to
CaRad53-S457E/S461E) elevated ScRad53 trans-autophosphor-
ylation activity in vitro. These data suggest that the C-terminal
SCD might confer MMS hypersensitivity in C. albicans via trans-
autophosphorylation of CaRad53. In support of this hypothesis,
we observed that strains expressing the CaRad53-S461D and
Figure 3. Detection of Rad53 downstream signalling by RT-PCR, Northern blot and qPCR in pph3D and psy2D cells. Fig 3A. Wild-type
(S5314 or BWP17), pph3D (SJL3) and psy2D (SJL6) cells were incubated at 30uC in YPD containing 0.02% MMS and then recovered with fresh YPD over
the indicated time period. RNA extracted from harvested cells at indicated time points was used for RT-PCR analysis. PCR amplifications in absence of
retrotranscriptase for each sample was used as negative controls in RT-PCR. GAPDH was used as loading control. Fig 3B. Wild-type (S5314 or BWP17),
pph3D (SJL3) and psy2D (SJL6) cells were incubated at 30uC in YPD containing 0.02% MMS for 6 h and then recovered with fresh YPD for 6 h. RNA was
extracted and subject to Northern blot analysis. GAPDH was used as control and rRNA was shown to indicate RNA integrity. Fig 3C. Wild-type (S5314
or BWP17), pph3D (SJL3) and psy2D (SJL6) cells were incubated at 30uC in YPD containing 0.02% MMS for 6 h and then recovered with fresh YPD over
the indicated time period. RNA was extracted and reverse transcribed into cDNA at the indicated time points for qPCR analysis. All data represent the
mean of 3 independent experiments.
doi:10.1371/journal.pone.0037246.g003
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MMS treatment in vivo but behaved similarly as the wild-type
protein in unperturbed conditions (Fig. 6A). Thus, we believe that
CaRad53 S461 and S545 contribute to but are not fully
responsible for activating the kinase activity. Additional factors
and/or pathways must be involved which need to be further
investigated.
Earlier studies demonstrated that Psy2 binds to the kinase
domain of Rad53 in S. cerevisiae [34]. Based on published mass
spectrometry results [32,59–63], Ser351 is phosphorylated upon
MMS treatment. Therefore, we performed viability assays using
the CaRad53-S351 mutants. Both S351D and S351A mutants
exhibited lower viability upon MMS treatment, with the S to D
mutant exhibiting a slightly stronger phenotype. We thus deduce
Figure 4. Rfa2 was downregulated in pph3D and pph3D ptc2D mutant upon MMS but not HU treatment. Fig 4A. Wild-type (HT1), pph3D
(HT2), psy2D (HT3), ptc2D (HT4) and pph3D ptc2D (HT5) cells were 10-fold serially diluted, spotted onto YPD plates containing different concentrations
of HU or MMS, and incubated at 30uC for 24 h. Fig 4B. Approximately equal numbers of yeast cells were spread onto YPD plates containing different
concentrations of HU and MMS for incubation at 30uC for 2 d. Percentage of viability was expressed as colony-forming units (CFU) of HU- or MMS-
treated mutants compared to untreated wild-type control. Fig 4C. Wild-type (HT1), pph3D (HT2), psy2D (HT3), ptc2D (HT4) and pph3D ptc2D (HT5)
cells expressing C-terminally Myc-tagged Rfa2 were incubated at 30uC in YPD containing 20 mM HU and recovered with fresh YPD over the indicated
time period. Untreated cells was used as control. Total protein was extracted from harvested cells at the indicated time points and subject to
immunoblot analysis with anti-Myc antibody. Cdc28 was probed with anti-PSTAIRE antibody as loading control. Fig 4D. Wild-type (HT1), pph3D (HT2),
psy2D (HT3), ptc2D (HT4) and pph3D ptc2D (HT5) cells expressing C-terminally Myc-tagged Rfa2 were incubated at 30uC in YPD containing 0.02%
MMS and recovered with fresh YPD over the indicated time period. Untreated cells were used as control. Total protein was extracted from harvested
cells at the indicated time points and subject to immunoblot analysis with anti-Myc antibody. Cdc28 was probed with anti-PSTAIRE antibody as
loading control.
doi:10.1371/journal.pone.0037246.g004
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37246that this mutation might have altered the kinase activity due to its
location in the activation loop of the Rad53 kinase. Hence, we
propose that S461 and S545 have a more important role in
determining MMS sensitivity in C. albicans.
Sequence alignment of ScRad53 and CaRad53 to their human
homolog Chk2 revealed that the C-terminal SCD is unique to the
yeast proteins, while the N-terminal SCD is present in yeast Rad53
and human Chk2. Phosphorylation of the SCDs is closely
associated with protein function and cell viability. For instance,
phosphorylation at ScRad53-T354 and ScRad53-T358 in the
activation loop is required for kinase activity [64–66]. Trans-
phosphorylation of the ScRad53 N-terminal SCD is crucial for
interaction with Dun1, the complex of which is involved in G2/M
checkpoint [67]. Chk2-T68 phosphorylation is dependent on
ATM/ATR and triggers Chk2 oligomerization, which led to
PIKK-independent kinase activation [66,68]. Furthermore, trans-
phosphorylation at ScRad53-S485 and ScRad53-S489 by Mec1
and Tel1 kinases was shown to affect Rad53 oligomerization
[63,69]. Phosphorylation of this region is critical for protein
function and hence cell viability [67,69]. Thus, our finding of S461
in this region of CaRad53 as a potential site for phosphoregulation
of cell’s sensitivity to MMS may be explored as targets for
developing for specific therapeutics to treat C. albicans infections.
Materials and Methods
Strains and culture conditions
All C. albicans strains used in this study are listed in Table 1.
Except where noted. C. albicans were routinely grown at 30uCi n
YPD medium (2% yeast extract, 1% peptone, and 2% glucose), in
GMM (2% glucose and 6.79 g/L yeast nitrogen base without
amino acids), or in GMM supplemented with the required
nutrients for auxotrophic mutants. Solid media contained 2%
agar.
Test of sensitivity to DNA damaging agents
Sensitivity to DNA-damaging agents was tested on solid or in
liquid medium. For growth on solid media, cells were first grown
in liquid YPD overnight at 30uC and 10-fold serially diluted with
fresh YPD to concentrations of 1610
2 to 1610
7 cells/mL; after
Figure 5. Viability assays of Rad53 phosphomimic mutants upon MMS and HU treatment. Fig 5A. Domain organizations of C. albicans
Rad53 and S. cerevisiae Rad53. Arrowheads mark [S/T]Q amino acid mutant site. Amino acids at domain boundaries are indicated by numbers.
Schematic description of the strategy for integrating RAD53 wild-type and mutant alleles at the RAD53 chromosomal locus (for details, see Materials
and Methods.). Fig 5B. Cells of wild-type (S5314 or BWP17), rad53D (WY3), the rescued RAD53 (HT6) and the various strains expressing mutant alleles
of RAD53 (HT7–18 refer to Table 1) were 10-fold serially diluted, spotted onto YPD plates containing different concentrations of HU or MMS, and
incubated at 30uC for 24 h. Fig 5C. Approximately equal numbers of cells of wild type (S5314 or BWP17), pph3D (SJL3), rad53D (WY3), the rescued
RAD53 (HT6) and the various strains expressing mutant alleles of RAD53 (HT13–16 rad53-S461A, rad53-S461D, rad53-S545A, rad53-S545D) were treated
with 20 mM HU or 0.02 mM for 2 h in liquid culture and then spread onto YPD plates for incubation at 30uC for 2 d. Percentage of viability was
expressed as CFU of the untreated mutants compared to untreated wild-type cells, and CFU of HU-treated or MMS-treated mutants was compared to
their untreated counterpart. All data show the average of three independent experiments with error bars. Fig 5D. Cells of wild type (S5314 or BWP17),
pph3D (SJL3), rad53D (WY3), the rescued RAD53 (HT6) and the various strains expressing mutant alleles of RAD53 (HT13–16 rad53-S461A, rad53-S461D,
rad53-S545A, rad53-S545D) were grown in liquid YPD medium supplemented with 0.02% MMS or 20 mM HU at 30uC for 4 h. Cells were collected for
microscopic examination. 0.02% MMS or 20 mM HU treated cells washed with fresh YPD and recovered into MMS-free and HU-free YPD at 30uC for
8 h. Cells were collected for microscopic examination. (Bar=5 mm)
doi:10.1371/journal.pone.0037246.g005
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plates containing different concentrations of HU or MMS and the
plates were photographed after 24 h incubation at 30uC. For
liquid cultures, cells were grown in YPD at 30uC overnight and
diluted with fresh YPD medium to a concentration of 5610
6 cells/
mL. After 2 h incubation at 30uC, MMS or HU was added to
a final concentration of 0.02% or 20 mM, respectively, and further
incubated for 2–12 h before the cells were harvested.
For DNA damage recovery experiments, harvested cells were
washed twice with distilled water after drug treatment, and
resuspended in fresh YPD medium for further growth. For cell
recovery rate assays, aliquots of 1610
3 cells/mL starting culture
were collected at timed intervals after drug treatment and spread
onto YPD plates where colony-forming units were counted after
1–2 d of incubation at 30uC.
Construction of C. albicans mutant strains
C. albicans homologs of corresponding S. cerevisiae genes were
identified in the C. albicans genome (http://www.candidagenome.
org) by sequence alignment. C. albicans deletion mutants were
constructed by sequentially deleting the two copies of the target
gene(s) with two deletion cassettes from the wild-type strain of
BWP17 [70,71]. The two deletion cassettes were constructed by
flanking a selectable marker gene (ARG4 or HIS1) with the AB and
CD DNA fragments (,400 bp each), that correspond to the 59
and 39 untranslated regions (UTRs) of the target gene, respectively
[21,38]. Homozygous deletion mutants were verified by PCR.
For rescue experiments, the entire open reading frame (ORF) of
the target gene, together with its promoter (21,000 bp), was
cloned into the CIp10-based, URA3-marked plasmid at KpnI and
ClaI sites, followed by the GAL4 39 UTR. The construct was
linearized by StuI, whose site exists in the RP10 sequence of
CIp10, and finally introduced into the gene deletion strains [21].
Construction of PPH3 and PSY2 deletion mutants carrying C-
terminal Myc-tagged Rad53 was carried out as previously
described [38].
To integrate C-terminal Myc-tagged Rfa2 into mutant strains of
various mutation alleles of RAD53, we used the URA3 flipper
strategy described previously [72]. First, one copy of RAD53 was
replaced with ARG4 as described above. Next, the coding sequence
of the second copy of RAD53 was deleted using a URA3 flipper
cassette, which was constructed by flanking the 4.2-kb URA3
flipper with the AB and CD DNA fragments corresponding to the
59 and 39 UTR of target gene. 5-FOA was then applied to delete
the URA3 flipper cassette constructs. Then, different mutation
alleles of RAD53 were integrated using HIS1 marker. Finally, C-
terminal Myc-tagged Rfa2 cloned in CIp10-based, URA3-marked
plasmid was linearized at a unique NsiI site, and transformed into
different RAD53 mutant strains described in the following context.
Similar procedures were taken for double mutation.
Site-directed mutagenesis of RAD53 was performed using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA). Primers used in this study are listed in Table S1.
Protein extraction, Western blotting and protein
dephosphorylation
To extract proteins, cells were harvested by centrifugation, and
,100 mg of cell pellet was resuspended in 300 ml of ice-cold RIPA
Table 2. Effects of the Rad53 S/T mutations on DNA checkpoint-mediated function.
Elongated cell
a (%) Elongated cell after recovery
a (%) Recovery rate
b
HU MMS HU MMS HU MMS
WT 95 83 4 10 +++++ +++++
pph3D 97 98 12 99* ++++ +*
rad53D 21 11 ++
RAD53 93 82 3 12 +++++ +++++
rad53-T327A 92 85 9 11 +++++ +++++
rad53-S350A 91 88 5 8 +++++ ++++
rad53-S351A 93 90 9 16 +++++ ++++
rad53-S461A 90 92 5 9 +++++ +++++
rad53-S545A 93 91 8 12 +++++ +++++
rad53-S695A 93 89 21 23 +++++ +++++
rad53-S4A
c 95 94 8 15 +++++ +++++
rad53-T327D 93 88 8 18 +++++ ++++
rad53-S350D 93 90 9 15 +++++ ++++
rad53-S351D 91 89 14 40 ++++ +++
rad53-S461D 93 95 10 93* +++++ ++**
rad53-S545D 98 99 32 90* +++++ ++**
rad53-S695D 91 94 18 22 +++++ +++++
rad53-S4D
c 93 95 14 95* +++++ ++**
a)Stationary-phase yeast cells were treated with 20 mM HU or 0.02 mM MMS in fresh YPD for 6 h, recover in fresh YPD for 8 h and the fractions of cells with an
elongated bud (length of bud 1.5 times that of the mother) were counted.
b)Equivalent numbers of yeast cells were treated with 20 mM HU or 0.02 mM MMS for 2 h and then same cell diluted before being spread onto YPD plates for counting
colony-forming units from few (+) to many (+++++) after a 2-d incubation at 30uC. Indicates *Pvalue,0.01; ** P value,0.05 compared with values from the control WT
cells.
c)rad53-S4A mean a quadruple mutant of S455A/S457A/S459A/S461A; rad53-S4D mean a a quadruple mutant of S455D/S457D/S459D/S461D.
doi:10.1371/journal.pone.0037246.t002
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beads (Sigma-Aldrich), the cells were lysed by four rounds of 45 s
of beating at 5,000 rpm in a MicroSmash MS-100 bead beater
(Tomy Medico, Minato-ku, Japan) with 2 min of cooling on ice
between rounds. Cell lysate supernatant was collected after
centrifugation at 13,000 rpm for 20 min at 4uC. Protein
concentration of the lysate was determined using bicinchoninic
acid (BCA) protein assay (Galen).
For Western blotting, 30 mg of total protein was separated by
10% or 12% SDS-PAGE and transferred to a polyvinylidene
difluoride (PVDF) membrane (Millipore). The membrane was
immersed in Tris-buffered saline containing 0.1% Tween 20
(TBST) and 5% non-fat dry milk for 1 h at room temperature,
followed by primary antibody and secondary antibody conjugated
with hydrogen peroxidase (HRP) or alkaline phosphatase (AP)
consecutively for 1 h each, both in TBST containing 1% milk.
The target protein was visualized by using an enhanced-
Figure 6. Detection of Rad53 downstream signaling by qPCR and Western blotting in pph3D cells and cells expressing various
mutant alleles of RAD53 upon MMS treatment. Fig 6A. Wild-type (SJL9), pph3D (SJL7), and the various strains expressing C-terminally Myc-
tagged mutant alleles of RAD53 (HT13.1–16.1 rad53-S461A, rad53-S461D, rad53-S545A, rad53-S545D cells were incubated at 30uC in YPD containing
0.02% MMS for 4 h, then washed and recovered with fresh YPD for the indicated times. Whole cell lysates were used for immunoblot analysis with
anti-Myc antibody. Untreated cells were used as control. Cdc28 was probed with anti-PSTAIRE antibody as loading control. Fig 6B. Cells of wild type
(S5314 or BWP17), pph3D (SJL3), rad53D (WY3), the rescued RAD53 (HT6) and the various strains expressing mutant alleles of RAD53 (HT13–16 rad53-
S461A, rad53-S461D, rad53-S545A, rad53-S545D) were were incubated at 30uC in YPD containing 20 mM HU and 0.02% MMS for 4 h, and then
recovered with fresh YPD for 6 h. RNA was extracted and reverse transcibed into cDNA for qPCR analysis. All data represent the mean of 3
independent experiments. (*Pvalue,0.01; ** P value,0.05). Fig 6C. Cells of wild type (HT1), pph3D (HT2) and the various RAD53 mutants expressing
C-terminally Myc-tagged Rfa2 (HT21–24 rad53-S461A Rfa2-myc, rad53-S461D Rfa2-myc, rad53-S545A Rfa2-myc and rad53-S545D Rfa2-myc) were
incubated at 30uC in YPD containing 0.02% MMS for 4 h and recovered with fresh YPD over the indicated time period. Untreated cells were used as
control. Total protein was extracted from harvested cells at the indicated time points and subject to immunoblot analysis with anti-Myc antibody.
Cdc28 was probed with anti-PSTAIRE antibody as loading control.
doi:10.1371/journal.pone.0037246.g006
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system. Anti-Myc and anti-Cdc28 (PSTAIRE) antibodies were
puchased from Santa Cruz (USA).
Protein dephosphorylation was carried out as described pre-
viously [30]. Lambda phosphatase was purchased from New
England BioLabs (catalog no. P07535).
Microscopy and flow cytometry
Staining of nuclei and chitin was carried out as previously
described [5]. Zeiss 510 metamicroscope and Cell Observer
system (Carl Zeiss MicroImaging, Germany) were used for
imaging. Flow cytometry was performed on Flow Cytometer BD
FACSVantage
TM SE system as described previously [21].
RNA isolation, RT-PCR, Northern blot and qPCR
Total RNA was obtained as previously described [73]. cDNA
was synthesized using the SuperScript II Reverse Transcriptase kit
(Invitrogen). RT-PCR was done according to the description of
Kelly, et al. (2004) [74]. Northern blot was performed according to
the description of Lane, et al. (2001) [75]. qPCR was performed
using the iQ SYBR Green Supermix (Bio-Rad) and detected via
the iCycler iQ detection system (Bio-Rad). Oligonucleotide
primers used to detect the transcripts of selected genes by RT-
PCR are shown in Table S1. qPCR was done using the following
program: initial denaturation at 94uC for 5 min, followed by 40
cycles of 94uC for 20 s, 56uC for 30 s, and 68uC for 20 s.
Amplification specificity was determined by melting curve analysis.
Supporting Information
Table S1 Oligonucleotide primers used for Construct,
RT-PCR and qPCR analysis.
(DOC)
Figure S1 pph3D and psy2D cells exhibit pseudohyphal
growth upon MMS treatment. Fig S1. Wild-type (SC5314 or
BWP17), pph3D (SJL3) and psy2D (SJL6) cells were grown in liquid
YPD medium supplemented with 0.02% MMS at 30uC for 6 h,
washed with fresh YPD and resuspended into fresh YPD for
further growth at 30uC for 8 h. Cells were collected for
microscopic examination at the indicated times. (Bar=5 mm).
(TIF)
Figure S2 pph3D and psy2D cells exhibit pseudohyphal
growth upon HU treatment. Fig S2. Wild-type (SC5314 or
BWP17), pph3D (SJL3) and psy2D (SJL6) cells were grown in liquid
YPD medium supplemented with 20 mM HU at 30uC for 6 h,
washed with fresh YPD and resuspended into fresh YPD for
further growth at 30uC for 8 h. Cells were collected for
microscopic examination at the indicated times. (Bar=5 mm).
(TIF)
Figure S3 Rad53p undergoes hyperphosphorylation in
response to HU and MMS. Fig S3A Rad53 hyperpho-
sphorylation in HU-treated cells. The lysate of SJL9 (wild-type
with RAD53-Myc), SJL7 (pph3D RAD53-Myc), and SJL8 (psy2D
RAD53-Myc) cells that were incubated at 30uC in YPD containing
20 mM HU for 4 h was divided into 2 parts. One was treated with
l-phosphatase (PPase), and the other was mock-treated with the
reaction buffer alone. The two samples, along with untreated cell
lysates, were then subjected to Western blot analysis using anti-
Myc antibody. Fig S3B Rad53 hyperphosphorylation in MMS-
treated cells. The lysate of SJL9 (wild-type with RAD53-Myc), SJL7
(pph3D RAD53-Myc), and SJL8 (psy2D RAD53-Myc) cells that were
incubated at 30uC in YPD containing 0.02% MMS for 4 h was
divided into 2 parts. One was treated with l-phosphatase (PPase),
and the other was mock-treated with the reaction buffer alone.
The two samples, along with untreated cell lysates, were then
subjected to Western blot analysis using anti-Myc antibody.
(TIF)
Figure S4 Detection of Rad53 hyperphosphorylation by
Western blotting in pph3D cells and cells expressing
various mutant alleles of RAD53 upon HU treatment. Fig
S4. Wild-type (SJL9), pph3D (SJL7), and the various strains
expressing C-terminally Myc-tagged mutant alleles of RAD53
(HT13.1–16.1 rad53-S461A, rad53-S461D, rad53-S545A, rad53-
S545D cells were incubated at 30uC in YPD containing 20 mM
HU for 4 h, then washed and recovered with fresh YPD for the
indicated times. Whole cell lysates were used for immunoblot
analysis with anti-Myc antibody. Untreated cells were used as
control. Cdc28 was probed with anti-PSTAIRE antibody as
loading control.
(TIF)
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